col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

34 Results       Page 1

Springer Science and Business Media LLC: Nature Reviews Drug Discovery
  original article Date Title Authors   All Authors
1 [GO] 2022―Oct―28 Pandemic vaccines: a formidable challenge for pharmacovigilance Alexandre Kiazand, Ruth Luther, Jessica Mårlind Würtele, Noel Southall, Douglas Domalik, Magnus Ysander
2 [GO] 2022―Jul―06 What should go into a booster shot for COVID-19? Asher Mullard
3 [GO] 2022―Jun―17 From pandemic preparedness to public-private partnerships Asher Mullard
4 [GO] 2022―Jan―28 A call to action for translational sciences in COVID-19 and future pandemics Kanny K. Wan, Danielle Davis, Taylor N. Lee, Stephanie L. Ford-Scheimer, Antonio L. Andreu, Florence Bietrix, et al. (+16)
5 [GO] 2022―Jan―17 2021 FDA approvals: value driven by COVID-19 vaccines Mathias Baedeker, Michael S. Ringel, Ulrik Schulze
6 [GO] 2021―Dec―07 Choosing drugs for UK COVID-19 treatment trials Patrick F. Chinnery, Marion Bonnet, Alison Cave, Matthias P. Hofer, Alastair Lamb, Glenn A. McConkey, et al. (+6)
7 [GO] 2021―Dec―06 Interfering viral-like particles inhibit SARS-CoV-2 replication M. Teresa Villanueva
8 [GO] 2021―Dec―02 A tale of two antiviral targets - and the COVID-19 drugs that bind them Megan Cully
9 [GO] 2021―Sep―09 PIKfyve: a lipid kinase target for COVID-19, cancer and neurodegenerative disorders Pei-Tzu Huang, Shirit Einav, Christopher R. M. Asquith
10 [GO] 2021―Sep―06 Pfizer’s COVID-19 vaccine secures first full FDA approval Asher Mullard
11 [GO] 2021―Jun―17 COVID-19 vaccine success enables a bolder vision for mRNA cancer vaccines, says BioNTech CEO Asher Mullard
12 [GO] 2021―May―17 COVID-19 impact on oncology clinical trials: a 1-year analysis Samik Upadhaya, Jia Xin Yu, Jeffrey Hodge, Jay Campbell
13 [GO] 2021―Apr―16 RECOVERY 1 year on: a rare success in the COVID-19 clinical trial landscape Asher Mullard
14 [GO] 2021―Mar―11 FDA authorizes first single-shot COVID-19 vaccine Asher Mullard
15 [GO] 2021―Feb―25 Trends in COVID-19 therapeutic clinical trials Kevin Bugin, Janet Woodcock
16 [GO] 2021―Jan―15 2020 FDA approvals: momentum kept despite COVID-19, but value falls Mathias Baedeker, Michael Ringel, Ulrik Schulze
17 [GO] 2020―Dec―04 COVID-19 vaccines buoy hope Asher Mullard
18 [GO] 2020―Nov―10 Impact of COVID-19 on pharmaceutical external innovation sourcing Lucas Robke, Lotte Berghauser Pont, Jens Bongard, Stephan Wurzer, Katarzyna Smietana, Rachel Moss
19 [GO] 2020―Sep―18 Immuno-oncology drug development forges on despite COVID-19 Samik Upadhaya, Vanessa M. Hubbard-Lucey, Jia Xin Yu
20 [GO] 2020―Sep―10 Clinical trial recovery from COVID-19 disruption John Z. Xue, Katarzyna Smietana, Pawel Poda, Kevin Webster, Guang Yang, Gaurav Agrawal
21 [GO] 2020―Sep―04 Evolution of the COVID-19 vaccine development landscape Tung Thanh Le, Jakob P. Cramer, Robert Chen, Stephen Mayhew
22 [GO] 2020―Sep―03 COVID-19 must catalyse changes to clinical development Rod MacKenzie, Peter Honig, Judy Sewards, Robert Goodwin, Marie-Pierre Hellio
23 [GO] 2020―Aug―05 Anti-IL-6Rs falter in COVID-19 Asher Mullard
24 [GO] 2020―Aug―05 COVID-19 vaccine guidelines Asher Mullard
25 [GO] 2020―Jul―07 COVID-19 platform trial delivers Asher Mullard
26 [GO] 2020―Jun―16 Immune status could determine efficacy of COVID-19 therapies Megan Cully
27 [GO] 2020―Jun―08 First antibody against COVID-19 spike protein enters phase I Asher Mullard
28 [GO] 2020―Jun―08 COVID-19 vaccines start moving into advanced trials Asher Mullard
29 [GO] 2020―May―18 Impact of COVID-19 on oncology clinical trials Samik Upadhaya, Jia Xin Yu, Cristina Oliva, Megan Hooton, Jeffrey Hodge, Vanessa M. Hubbard-Lucey
30 [GO] 2020―May―14 Remote digital monitoring in clinical trials in the time of COVID-19 Jennifer C. Goldsack, Elena S. Izmailova, Joseph P. Menetski, Steven C. Hoffmann, Peter M.A. Groenen, John A. Wagner
31 [GO] 2020―Apr―09 The COVID-19 vaccine development landscape Tung Thanh Le, Zacharias Andreadakis, Arun Kumar, Raúl Gómez Román, Stig Tollefsen, Melanie Saville, Stephen Mayhew
32 [GO] 2020―Apr―08 COVID-19 brings drug development to a halt Asher Mullard
33 [GO] 2020―Apr―08 Coordinating the COVID-19 pipeline Asher Mullard
34 [GO] 2020―Feb―10 Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Guangdi Li, Erik De Clercq

34 Results       Page 1


Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec